Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-082132
Filing Date
2024-07-24
Accepted
2024-07-24 08:18:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2416389-2_424b5.htm 424B5 628601
2 GRAPHIC lg_transcodetheratm-4c.jpg GRAPHIC 43878
  Complete submission text file 0001104659-24-082132.txt   686015
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-268764 | Film No.: 241136196
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)